 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: December 2025
Volume 10 | Issue 12
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 115
Article Submitted : 19451
Article Published : 8041
Total Authors : 21252
Total Reviewer : 769
Total Countries : 144
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Biosketch of Anti-Malarial Drug |
| Authors Name: | Vaishnavi Prakash Lande , Harishkumar Rathod , Dr. Swati Deshmukh |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_188408
|
| Published Paper Id: | IJRTI2312048 |
| Published In: | Volume 8 Issue 12, December-2023 |
| DOI: | |
| Abstract: | Abstract Malaria continues to affect public health and economic growth in many regions of the world. The number of infections continues to rise and is associated with increased mortality, despite basic science and public health efforts. Drug therapy remains the mainstay of treatment and prevention of this disease. Plasmodium has a complex life cycle involving an arthropod vector and distinct stages within the human host. Each parasite stage plays a unique role in transmission, disease, and latency. These different stages may vary in their response to the various antimalarial compounds. This article will review antimalarial therapies and drug resistance in the context of the parasites' biology. For control malaria are used & elimination of rantimalarial drugs. Because of development of artemisinin the combination therpies in burden based decrease of malaria. There is potential spread of artemisinin. Resistant Urgent parasites in Asia have raised Concerns Due to this threat the TCEMRS. International Centers of Excellence for malaria Research ane studying the mechanism & underlying doug resistance Research activities. Are taken at multiple sentinel sites of the global ICEMR network For ex vivo/ in vitro assays to measure droug ceptibilities of parasites isolates & charcterisation of resistance – megreting panasite polymerphisms. From this we antimalarial review Worldwild drug resistance concerns Summarize research activitie of the ICEMRS related to droug resistance Self-medication for malaria is very common in Sub-Saharan Africa where this parasitosis is endemic. In order to determine the extent, characteristics and factors associated with this practice in medical area in the city of Lubumbashi, a cross-sectional descriptive study was carried out by direct interview from January 2018 to June 2018, in the internal medicine departments of 10 General Referral Hospital (GRH). Five thousand one hundred and thirty- four patients were consulted among them, 96.6% (average age 38.7 ± 8 years; average income: 100+ 12 USD; gender male/female ratio: 0.86) practice self-medication with antimalarials. They used it for the first time at an average age of 13-17 years. Quinine (36.4%) and Carica papaya (0.4%) are the most used remedies in conventional and non-conventional medicine, respectively. Several risks are incurred during this practice when the most cited are worsening side effects (53%), incomplete treatment (37%) and appearance to health sciences (37%). Age (17-35 and > 65 years old), low income (50-150 USD), membership in a health sector and the claim to know antimalarial drugs, predispose patients to self-medication. There is an urgent need to regulate this practice to avoid its harmful consequences. Area study Lubumbashi (DR Congo) Descriptive study by interview (n: 5134) in 10 General Referral Hospital Prevalence of self- |
| Keywords: | Anti-Malarial , Artemisinin , Quinine , Parasitosisi. |
| Cite Article: | "Biosketch of Anti-Malarial Drug ", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 12, page no.347 - 353, December-2023, Available :http://www.ijrti.org/papers/IJRTI2312048.pdf |
| Downloads: | 000205258 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2312048
Registration ID:188408
Published In: Volume 8 Issue 12, December-2023
DOI (Digital Object Identifier):
Page No: 347 - 353 Country: Washim , Maharashtra , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2312048 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2312048 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||